Back

Results of systemic fibrinolysis vs. ECMO VA in patients with profound shock (SCAI D-E) due to acute pulmonary embolism

20 March 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Treatment ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Eduardo Lujan Valencia

Marquis of Valdecilla University Hospital, Santander (Spain)

71 More presentations in this session

Presentation thumbnail
Multimodality imaging of the aortic root and ascending aorta: a comparative study of CTA and echocardiography
Mr G. Imperatore (Pisa, IT)
Abstract Slides
Presentation thumbnail
Impact of atrial fibrillation burden on heart failure device alerts and therapy delivery: insights from remote monitoring in an island-based heart failure cohor
Doctor I. Almeida (Ponta Delgada, PT)
Abstract Slides
Presentation thumbnail
Respiratory infections as triggers of acute cardiovascular complications: a case series of new-onset atrial fibrillation and heart failure
Doctor A. Akhtar (Waterford, IE)
Abstract Slides
Presentation thumbnail
Stabilizing the unstable: characterization of advanced heart failure patients under intermittent levosimendan therapy
Doctor R. Brandao (Amadora, PT)
Abstract Slides
Presentation thumbnail
Predictors of Levosimendan reinitiation in patients with advanced heart failure undergoing intermittent inotropic therapy- is the lung that important?
Doctor R. Brandao (Amadora, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster session (1)

The Event

Event poster

ESC Acute CardioVascular Care 2026

20 March 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Endovascular treatment of pulmonary embolism: experience from a tertiary center
thumbnail
Congress Presentation
Mechanical circulatory support in high-risk PE for more than a decade.
thumbnail
Congress Presentation
Outcomes in patients with intermediate-high risk pulmonary embolism submitted to catheter-directed therapy presenting with normotensive-shock

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources